Publications Repository

Publications Repository

View Item 
  •   Home
  • ICR Divisions
  • Breast Cancer Research
  • View Item
  • Home
  • ICR Divisions
  • Breast Cancer Research
  • View Item
JavaScript is disabled for your browser. Some features of this site may not work without it.

CYP3A7*1C allele is associated with reduced levels of 2-hydroxylation pathway oestrogen metabolites.

Thumbnail
View/Open
Accepted version (667.6Kb)
Publication Date
2017-01
ICR Author
Fletcher, Olivia
Author
Sood, D
Johnson, N
Jain, P
Siskos, AP
Bennett, M
Gilham, C
Busana, MC
Peto, J
Dos-Santos-Silva, I
Keun, HC
Fletcher, O
Type
Journal Article
Metadata
Show full item record
Abstract
BACKGROUND: Endogenous sex hormones are well-established risk factors for breast cancer; the contribution of specific oestrogen metabolites (EMs) and/or ratios of specific EMs is less clear. We have previously identified a CYP3A7*1C allele that is associated with lower urinary oestrone (E1) levels in premenopausal women. The purpose of this analysis was to determine whether this allele was associated with specific pathway EMs. METHODS: We measured successfully 12 EMs in mid-follicular phase urine samples from 30 CYP3A7*1C carriers and 30 non-carriers using HPLC-MS/MS. RESULTS: In addition to having lower urinary E1 levels, CYP3A7*1C carriers had significantly lower levels of four of the 2-hydroxylation pathway EMs that we measured (2-hydroxyestrone, P=1.1 × 10-12; 2-hydroxyestradiol, P=2.7 × 10-7; 2-methoxyestrone, P=1.9 × 10-12; and 2-methoxyestradiol, P=0.0009). By contrast, 16α-hydroxylation pathway EMs were slightly higher in carriers and significantly so for 17-epiestriol (P=0.002). CONCLUSIONS: The CYP3A7*1C allele is associated with a lower urinary E1 levels, a more pronounced reduction in 2-hydroxylation pathway EMs and a lower ratio of 2-hydroxylation:16α-hydroxylation EMs in premenopausal women. To further characterise the association between parent oestrogens, EMs and subsequent risk of breast cancer, characterisation of additional genetic variants that influence oestrogen metabolism and large prospective studies of a broad spectrum of EMs will be required.
URL
https://repository.icr.ac.uk/handle/internal/321
Collections
  • Breast Cancer Research
Licenseref URL
https://creativecommons.org/licenses/by/4.0
Version of record
10.1038/bjc.2016.432
Subject
Adolescent
Adult
Alleles
Breast Neoplasms
Cytochrome P-450 CYP3A
Down-Regulation
Estrogens
Estrone
Female
Genetic Carrier Screening
Humans
Hydroxylation
Metabolic Networks and Pathways
Middle Aged
Premenopause
Risk Factors
Young Adult
Research team
Functional Genetic Epidemiology
Language
eng
Date accepted
2016-12-01
License start date
2017-01
Citation
Br J Cancer, 2017, 116 (3), pp. 382 - 388

Browse

All of ICR repositoryICR Divisions & RM Clinical UnitsIssue dateAuthorsTitlesSubjectsThis collectionIssue dateAuthorsTitlesSubjects

Statistics

Most popular itemsStatistics by countryMost popular authors
  • Login
  • Registered office: The Institute of Cancer Research, 123 Old Brompton Road, London, SW7 3RP
    A Charity, Not for Profit. Company Limited by Guarantee.
    Registered in England No. 534147. VAT Registration No. GB 849 0581 02.